BETHLEHEM, Pa., Sept. 10, 2009 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral fluid diagnostics, today announced that Robert A. Gregg, Ph.D., has been appointed as the Company's Vice President, Regulatory Affairs and Quality Assurance, effective September 14, 2009.
In this capacity, Dr. Gregg will have responsibility for the Company's regulatory, quality assurance and clinical affairs functions. Dr. Gregg will report to Douglas A. Michels, OraSure's President and CEO.
Dr. Gregg joins OraSure with extensive experience in global regulatory affairs, including over 25 years of relevant experience in the medical device and diagnostics industries with such organizations as Roche Diagnostics, Johnson & Johnson and the U.S. Food and Drug Administration ("FDA").
"We are extremely pleased that Bob has chosen to join OraSure Technologies," said Michels. "His broad experience in regulatory, clinical and quality will be of enormous value to the Company. This will be especially important as we continue to expand our product portfolio and global presence, while building upon our leadership position in the industry."
Since 2004, Dr. Gregg had served as Vice President, Corporate Regulatory Affairs and Quality Systems at PerkinElmer, Inc., a global leader in health sciences. From 1998 to 2004, Dr. Gregg served as the Director of Regulatory Affairs at Roche Diagnostics, where he was responsible for various business units including immunology-based technologies in the areas of infectious diseases, microbiology and clinical chemistries. Prior to his work at Roche, Dr. Gregg was the Executive Director of Regulatory Affairs and Quality Assurance at the Direct Access Diagnostics division of Johnson & Johnson, where he directed the approval of the first HIV home collection test kit. Early in his career, he was a Biologist/Fellow at the U.S. Food and Drug and Administration.
Dr. Gregg received his Ph.D. in Biology from Georgetown University and a B.A. in Biology/Chemistry from College of St. Rose.
About OraSure Technologies
OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. For more information on the Company, please go to www.orasure.com.
The OraSure Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6440
CONTACT: OraSure Technologies, Inc.
Investor Contact:
Ronald H. Spair, Chief Financial Officer
610-882-1820
Investorinfo@orasure.com
Zer0 to 5ive
Media Contact:
Marybeth Sheppard
646-808-4986
Marybeth@0to5.com
